# L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

> **NCT05446415** · NA · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Severe Obesity
- Type 2 Diabetes Mellitus in Obese

## Interventions

- **OTHER:** Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.

## Key facts

- **NCT ID:** NCT05446415
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-05
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-12-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446415, "L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05446415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*